Multidisciplinary Treatment of Cancer of the Rectum: A European Approach

Surgical Oncology Clinics of North America

Volumn 17, Issue 3, 2008, Pages 533-551

  Nicholls, R J ^a,b   Tekkis, Paris P ^a,b  

^a ST MARY S HOSPITAL   (United Kingdom)

^b ST MARK S HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

FLUOROURACIL; FOLINIC ACID;

ACUTE TOXICITY; ADJUVANT THERAPY; CANCER LOCALIZATION; CANCER MORTALITY; CANCER RADIOTHERAPY; CANCER RECURRENCE; CANCER STAGING; CHRONIC TOXICITY; CLINICAL TRIAL; COMBINATION CHEMOTHERAPY; EUROPE; HUMAN; INTERMETHOD COMPARISON; MORBIDITY; PATIENT COMPLIANCE; POSTOPERATIVE CARE; POSTOPERATIVE RADIOTHERAPY; PREOPERATIVE EVALUATION; PREOPERATIVE RADIOTHERAPY; RADIATION INJURY; RECTUM CANCER; REVIEW; SHORT COURSE THERAPY; TREATMENT RESPONSE;

COMBINED MODALITY THERAPY; EUROPE; HUMANS; NEOPLASM RECURRENCE, LOCAL; NEOPLASM STAGING; PATIENT CARE TEAM; POSTOPERATIVE PERIOD; PREOPERATIVE CARE; RECTAL NEOPLASMS; TREATMENT OUTCOME;

EID: 43449133556     PISSN: 10553207     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.soc.2008.02.008     Document Type: Review

References (83)

1. Heald R.J., Husband E.M., and Ryall R.D. The mesorectum in rectal cancer surgery-the clue to pelvic recurrence?. Br J Surg 69 10 (1982) 613-616
2. Quirke P., Durdey P., Dixon M.F., et al. Local recurrence of rectal adenocarcinoma due to inadequate surgical resection. Histopathological study of lateral tumour spread and surgical excision. Lancet 2 8514 (1986) 996-999
3. Hall N.R., Finan P.J., al-Jaberi T., et al. Circumferential margin involvement after mesorectal excision of rectal cancer with curative intent. Predictor of survival but not local recurrence?. Dis Colon Rectum 41 8 (1998) 979-983
4. Heald R.J., and Ryall R.D. Recurrence and survival after total mesorectal excision for rectal cancer. Lancet 1 8496 (1986) 1479-1482
5. Beets-Tan R.G., Beets G.L., Vliegen R.F., et al. Accuracy of magnetic resonance imaging in prediction of tumour-free resection margin in rectal cancer surgery. Lancet 357 9255 (2001) 497-504
6. Daniels I., Fisher S.E., Heald R.J., et al. Accurate staging, selective preoperative therapy and optimal surgery improves outcome in rectal cancer: a review of the recent evidence. Colorectal Dis 9 (2007) 290-301
7. Martling A., Holm T., Rutqvist L.E., et al. Effect of training programme on outcome of rectal cancer in the County of Stockholm. Lancet 356 (2000) 497-504
8. Wibe A., Moller B., Norstein J., et al. A national strategic change in treatment policy for rectal cancer-implementation of total mesorectal excision as routine treatment in Norway. A national audit. Dis Colon Rectum 45 (2002) 857-866
9. Iversen L., Harling H., Laurberg S., et al. Influence of caseload and surgical specialty on outcome following surgery for colorectal cancer: a review of evidence. Part 2: long-term outcome. Colorectal Dis 9 (2007) 38-46
10. Birbeck K., Macklin C.P., Tiffin N.J., et al. Rates of circumferential resection margin involvement vary between surgeons and predict outcomes in rectal cancer surgery. Ann Surg 235 (2002) 449-457
11. Nagtegaal I.D., van de Velde C.J., Marijnen C.A., et al. Low rectal cancer: a call for a change of approach in abdominoperineal resection. J Clin Oncol 23 (2005) 9257-9264
12. Wibe A., Syse A., Andersen E., et al. Oncological outcome after total mesorectal excision for cure for cancer of the lower rectum: anterior vs abdominoperineal resection. Dis Colon Rectum 47 (2004) 48-58
13. Sauer I., and Bacon H.E. A new approach for excision of carcinoma of the lower portion of the rectum and anal canal. Surg Gynecol Obstet 95 (1952) 229-242
14. Deddish M., and Stearns M.W. Anterior resection for carcinoma of the rectum and sigmoid area. Ann Surg 154 (1961) 961-966
15. Hojo K., Koyama Y., and Moriya Y. Lymphatic spread and its prognostic value in patients with rectal cancer. Am J Surg 144 (1982) 350-354
16. Berge T., Ekelund G., Mellner C., et al. Carcinoma of the colon and rectum in a defined population. Acta Chir Scand Suppl 4 (1973) 38-51
17. Dukes C., and Bussey H.J.R. The spread of rectal cancer and its effect on prognosis. Br J Cancer 12 (1958) 209-220
18. Nicholls R.J., and Hall C. Treatment of non-disseminated cancer of the lower rectum. Br J Surg 83 1 (1996) 15-18
19. Merkel S., Mansmann U., Siassi M., et al. The prognostic inhomogeneity of pT3 carcinoma. Int J Colorectal Dis 16 (2001) 298-304
20. Mackay S.G., Pager C.K., Joseph D., et al. Assessment of the accuracy of transrectal ultrasonography in anorectal neoplasia. Br J Surg 90 3 (2003) 346-350
21. Garcia-Aguilar J., Pollack J., Lee S.H., et al. Accuracy of endorectal ultrasonography in preoperative staging of rectal tumors. Dis Colon Rectum 45 (2002) 10-15
22. Beets-Tan R.G. MRI in rectal cancer: the T stage and circumferential resection margin. Colorectal Dis 5 (2003) 392-395
23. Brown G., Radcliffe A.G., Newcombe R.G., et al. Preoperative assessment of prognostic factors in rectal cancer using high-resolution magnetic resonance imaging. Br J Surg 90 3 (2003) 355-364
24. Purkayastha S., Tekkis P.P., Athanasiou T., et al. Diagnostic precision of magnetic resonance imaging for preoperative prediction of the circumferential margin involvement in patients with rectal cancer. Colorectal Dis 9 (2007) 402-411
25. Brown G., Richards C.J., Bourne M.W., et al. Morphologic predictors of lymph node status in rectal cancer with use of high-spatial-resolution MR imaging with histopathologic comparison. Radiology 227 2 (2003) 371-377
26. Will O., Purkayastha S., Chan C., et al. Diagnostic precision of nanoparticle-enhanced MRI for lymph-node metastases: a meta-analysis. Lancet Oncol 7 (2006) 52-60
27. Williams I., and Horwitz H. The primary treatment of adenocarcinoma of the rectum by high voltage Roentgen rays (1000 kv). Am J Roentgenol 76 (1956) 919-928
28. Wang C., and Schulz M.D. The role of radiation therapy in the management of carcinoma of the sigmoid, rectosigmoid and rectum. Radiology 79 (1962) 1-5
29. Stevens K., Allen C.V., and Fletcher W.S. Preoperative radiotherapy for adenocarcinoma of the rectosigmoid. Cancer 37 (1976) 2866-2874
30. Economou S., and Cole W.H. Chemotherapy of cancer of the alimentary tract. Surg Clin North Am 42 (1962) 1147-1170
31. O'Connell M., Childs D.S., Moertel C.G., et al. A prospective controlled evaluation of combined radiotherapy and methanol residue of BCG (MER) for locally resectable or recurrent rectal carcinoma. Int J Radiat Oncol Biol Phys 8 (1982) 115-119
32. Boulis Wassif S. Ten years' experience with a multidisciplinary treatment of advanced stages of rectal cancer. Cancer 52 (1983) 2017-2024
33. Cummings B., Rider W.D., Harwood A.R., et al. Radical external beam radiation therapy for adenocarcinoma. Dis Colon Rectum 26 (1983) 30-36
34. Papillon J. Intracavitary irradiation of early rectal cancer for cure. Cancer 36 (1975) 696-701
35. Chambers W., Khan U., Gagliano A., et al. Tumour morphology as a predictor of outcome after local excision of rectal cancer. Br J Surg 91 (2004) 457-459
36. Rider W., Palmer J.A., Mahoney L.J., et al. Preoperative irradiation of inoperable cancer of the rectum; report of the Toronto Trial. Can J Surg 20 (1977) 335-338
37. Stearns M., Deddish M.R., Quan S.H.W., et al. Preoperative Roentgen therapy for cancer of the rectum and rectosigmoid. Surg Gynecol Obstet 138 (1974) 584-592
38. Roswit B., Higgins G.A., and Keehn R.J. Preoperative irradiation for carcinoma of the rectum and rectosigmoid colon. Report of a national VA randomised study. Cancer 35 (1975) 1597-1602
39. Higgins G., Donaldson R.C., Dannenberg P., et al. Adjuvant therapy for large bowel cancer. Update of VA Surgical Oncology Group Trials. Surg Clin North Am 61 (1981) 1311-1320
40. Papillon J. The true role of external-beam irradiation in the initial treatment of cancer of the rectum. Recent Results Cancer Res 110 (1988) 114-118
41. Mohiuddin M., and Marks G. High dose preoperative irradiation for cancer of the rectum, 1976-1988. Int J Radiat Oncol Biol Phys 20 (1991) 37-43
42. First report of the MRC working party. Br J Surg 69 (1982) 513-519
43. Hoskins B., Gunderson L., Dosoretz D., et al. Adjuvant postoperative radiotherapy in carcinoma of the rectum and rectosigmoid. Int J Radiat Oncol Biol Phys 6 (1980) 1379
44. Mohiuddin M., Marks G., Kramer S., et al. Adjuvant radiation therapy for rectal cancer. Int J Radiat Oncol Biol Phys 10 (1984) 977-980
45. Withers H., Romsdahl M.D., and Suxton G. Postoperative radiotherapy for cancer of the rectum and rectosigmoid. American Society for Therapeutic Radiology Proceedings. Int J Radiat Oncol Biol Phys 6 (1980) 1380
46. Balslev I., Pedersen M., Teglbjaerg P.S., et al. Postoperative radiotherapy in Dukes B and C carcinoma of the rectum and rectosigmoid. A randomised multicenter study. Cancer 58 (1986) 22-28
47. Gastrointestinal Tumor Study Group. Prolongation of the disease-free interval in surgically treated rectal carcinoma. N Engl J Med 312 (1985) 1464-1472
48. Thomas P., Stablein D.M., Lindblad A.M., et al. Toxicity associated with adjuvant postoperative therapy for adenocarcinoma of the rectum. Int J Radiat Oncol Biol Phys 9 Suppl 1 (1983) 137
49. Medical Research Council Working Party. Randomised trial of surgery alone versus radiotherapy followed by surgery for potentially operable locally advanced rectal cancer. Lancet 348 (1996) 1605-1610
50. NIH Consensus Conference. Adjuvant therapy for patients with colon and rectal cancer. JAMA 264 (1990) 1444-1450
51. Camma C., Giunta M., Fiorica F., et al. Preoperative radiotherapy for resectable rectal cancer. JAMA 284 (2000) 1008-1015
52. Colorectal Cancer Collaborative Cancer Group. Adjuvant therapy for rectal cancer: a systematic review of 8,507 patients from 22 randomised trials. Lancet 358 (2001) 1291-1304
53. Pahlman L., Glimelius B., and Graffman S. Pre- versus postoperative radiotherapy in rectal carcinoma: an interim report from a randomized multicentre trial. Br J Surg 72 12 (1985) 961-966
54. Pahlman L., and Glimelius B. Pre- or postoperative radiotherapy in rectal and rectosigmoid carcinoma. Report from a randomized multicenter trial. Ann Surg 211 2 (1990) 187-195
55. Sauer R., Becker H., Hohenberger W., et al. Preoperative versus postoperative chemoradiotherapy for rectal cancer. N Engl J Med 351 (2004) 1731-1740
56. Gerard A., Buyse M., Nordlinger B., et al. Preoperative radiotherapy as adjuvant treatment in rectal cancer. Final results of a randomized study of the European Organization for Research and Treatment of Cancer (EORTC). Ann Surg 208 5 (1988) 606-614
57. Dahl O., Horn A., Morild I., et al. Low-dose preoperative radiation postpones recurrences in operable rectal cancer: results of a randomised multicenter trial in western Norway. Cancer 66 (1990) 2286-2294
58. Goldberg P.A., Nicholls R.J., Porter N.H., et al. Long-term results of a randomised trial of short-course low-dose adjuvant pre-operative radiotherapy for rectal cancer: reduction in local treatment failure. Eur J Cancer 30A 11 (1994) 1602-1606
59. Cedermark B., Johansson H., Rutqvist L.E., et al. The Stockholm I trial of preoperative short term radiotherapy in operable rectal carcinoma. A prospective randomized trial. Stockholm Colorectal Cancer Study Group. Cancer 75 9 (1995) 2269-2275
60. Martling A., Holm T., Johansson H., et al. The Stockholm II trial on preoperative radiotherapy in rectal carcinoma: long-term follow-up of a population-based study. Cancer 92 (2001) 896-902
61. Kirk J., Gray W.M., and Watson E.R. Cumulative radiation effect. Fractionated treatment regimes. Clin Radiol 22 (1971) 145-155
62. Swedish Rectal Cancer Trial Group. Improved survival with preoperative radiotherapy in resectable rectal cancer. N Engl J Med 336 (1997) 980-987
63. Folkesson J., Birgisson H., Pahlman L., et al. Swedish Rectal Cancer Trial: long lasting benefit from radiotherapy on survival and local recurrence rate. J Clin Oncol 23 (2005) 5644-5650
64. Kapiteijn E., Marijnen C.A., Nagtegaal I.D., et al. Preoperative radiotherapy combined with total mesorectal excision for resectable rectal cancer. N Engl J Med 345 9 (2001) 638-646
65. Peeters K., Marijnen C.A.M., Nagtegaal I.D., et al. Increased local control but no survival benefit in irradiated patients with resectable rectal carcinoma. Ann Surg 246 (2007) 693-701
66. Marijnen E., Peeters J.C.M.J., Putter H., et al. Long term results, toxicity and quality of life in the TME trial. Radiother Oncol 73 Suppl 1 (2004) S127
67. Bujko K., Nowacki M.P., Nasierowska-Guttmejer A., et al. Long-term results of a randomised trial comparing preoperative short-course radiotherapy with preoperative conventionally fractionated chemoradiation for rectal cancer. Br J Surg 93 (2006) 1215-1223
68. Sebag-Montefiore D., Steele R., Quirke P., et al. Short course pre-operative radiotherapy results improves outcome when compared with highly selective postoperative chemotherapy. Preliminary results of the MRC CR07 randomised trial. Radiother Oncol 81 S1 (2006) S19
69. Quirke P., Sebag-Montefiore D., Steele R., et al. The rate of local recurrence after rectal cancer resection is strongly related to the plane of surgical dissection and is further reduced by pre-operative short course radiotherapy. Preliminary results of the Medical Research Council (MRC) CR07 Trial. Radiother Oncol 81 S1 (2006) S93
70. Bosset J.F., Collette L., Calais G., et al. Chemotherapy with preoperative radiotherapy for rectal cancer. N Engl J Med 355 (2006) 1114-1123
71. Peeters K., van de Velde C.J., Leer J.W., et al. Late side effects of short-course preoperative radiotherapy combined with total mesorectal excision for rectal cancer: increased bowel dysfunction in irradiated patients-a Dutch Colorectal Cancer Group study. J Clin Oncol 23 (2005) 6199-6206
72. Pietrzak L., Bujko K., Nawacki M.P., et al. Quality of life, anorectal and sexual functions after preoperative radiotherapy for rectal cancer: report of a randomised trial. Radiother Oncol 84 (2007) 217-225
73. Dworak O., Keilholz L., and Hoffmann A. Pathological features of rectal cancer after preoperative radiotherapy. Int J Colorectal Dis 12 (1997) 19-23
74. Rodel C., Grabenbauer G.G., Papadopoulos T., et al. Apoptosis as a cellular predictor for histopathologic response to neoadjuvant radiochemotherapy in patients with rectal cancer. Int J Radiat Oncol Biol Phys 52 (2002) 294-303
75. Rodel K., Martus P., Papadoupolos T., et al. Prognostic significance of tumor regression after preoperative chemoradiotherapy for rectal cancer. J Clin Oncol 23 (2005) 8688-8696
76. Mandard A., Dalibard F., Mandard J.C., et al. Pathologic assessment of tumor regression after preoperative chemoradiotherapy of esophageal carcinoma: clinicopathological correlations. Cancer 73 (1994) 2680-2686
77. Vecchio F., Valentini V., Minsky B., et al. The relationship of pathologic tumor grade (TRG) and outcomes after preoperative therapy in rectal cancer. Int J Radiat Oncol Biol Phys 62 (2005) 752-760
78. Guillem J., Chessin D.B., Shia J., et al. A prospective pathologic analysis using whole-mount sections of rectal cancer following preoperative combined modality therapy: implications for sphincter preservation. Ann Surg 245 (2007) 88-93
79. Bouzourene H., Bosman F.T., Seelentag W., et al. Importance of tumor regression assessment in predicting the outcome in patients with locally advanced rectal carcinoma who are treated with preoperative radiotherapy. Cancer 94 (2002) 1121-1130
80. Gerard J.-P., Chapet O., Nemoz C., et al. Improved sphincter preservation in low rectal cancer with high-dose preoperative radiotherapy: the Lyon R96-02 randomised trial. J Clin Oncol 22 (2004) 2404-2409
81. Habr-Gama A., Perez R.O., Nadalin W., et al. Operative versus non-operative treatment for stage 0 distal rectal cancer following chemoradiation therapy: long-term results. Ann Surg 240 (2004) 711-717
82. Habr-Gama A. Assessment and management of the cojmplete clinical responce of rectal cancer to chemoradiotherapy. Colorectal Dis 8 Suppl 3 (2006) 21-24
83. Bujko K., Kepka L., Michalki W., et al. Does rectal cancer shrinkage induced by preoperative radiotherapy increase the likelihood of anterior resection? A systematic review of randomised trials. Radiother Oncol 80 (2006) 4-12